Table 5. Cox proportional hazard regression by treatment regimen for PKDL; MDAMB as a reference group.
| Treatment regimen | Unadjusted hazard ratio (95% CI) |
P-value | Adjusted hazard ratio (95% CI)a |
P-value |
|---|---|---|---|---|
| MDAMB | 1 | — | 1 | — |
| MF | 1.2 (0.5, 2.8) | 0.67 | 1.2 (0.5, 2.9) | 0.62 |
| AMB+PMIM | 1.4 (0.6, 3.3) | 0.45 | 1.2 (0.5, 2.9) | 0.63 |
| SDAMB | 2.1 (0.9, 4.6) | 0.06 | 2.0 (0.9, 4.4) | 0.08 |
| AMB+MF | 2.1 (0.9, 4.7) | 0.06 | 2.3 (1.0, 5.2) | 0.04 |
| PMIM | 2.5 (1.1, 5.5) | 0.02 | 2.3 (1.0, 5.0) | 0.04 |
| PMIM+MF | 3.2 (1.5, 6.9) | 0.003 | 3.0 (1.4, 6.5) | 0.005 |
AMB = AmBisome. MDAMB = multidose liposomal amphotericin B (AmBisome). MF = miltefosine. No. = number. PKDL = post-kala-azar dermal leishmaniasis. PMIM = paromomycin intramascular injection. SDAMB = single-dose liposomal amphotericin B (AmBisome). VL = visceral leishmaniasis.
a Adjusted covariates: Age, Gender, Education, Monthly household expenditure, Number of family members in the household, Family member affected by VL in the past, Type of house, Presence of cattle shed, Number of bednets in the household, How often is the bednet used.